Genomic integrity of human induced pluripotent stem cells across nine studies in the NHLBI NextGen program
Open Access
- 6 May 2020
- journal article
- research article
- Published by Elsevier in Stem Cell Research
- Vol. 46, 101803
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK116074)
- University of Washington
- National Heart, Lung, and Blood Institute (U01 HL107388, U01 HL107393, U01 HL107436, U01 HL107437, U01 HL107440, U01 HL107442, U01 HL107443, U01 HL107446, U01 HL72518-05)
- National Human Genome Research Institute (R01 HL112064, U01 HG006398)
This publication has 54 references indexed in Scilit:
- BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell CulturesStem Cell Reports, 2013
- Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantageNature Biotechnology, 2011
- Performance assessment of copy number microarray platforms using a spike-in experimentBioinformatics, 2011
- Somatic coding mutations in human induced pluripotent stem cellsNature, 2011
- Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in CultureCell Stem Cell, 2011
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- The promises and perils of p53Nature, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004